← Open Payments lookup

BENJAMIN WILSON: Open Payments

NPI 1417247644 · NEVADA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$620 in 31 payments from 14 companies in 2025. Trend: 2023 $608 · 2024 $563 · 2025 $620

Food & beverage: $620
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$164
Vanda Pharmaceuticals Inc.3$81
ABBVIE INC.4$68
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$50
Lilly USA, LLC2$42
Pacira Pharmaceuticals Incorporated2$39
Bayer Healthcare Pharmaceuticals Inc.2$30
Otsuka America Pharmaceutical, Inc.1$29
Astellas Pharma US Inc1$24
Novo Nordisk Inc1$21

Products named: CAPLYTA, FANAPT, VRAYLAR, XIFAXAN, MOUNJARO, Iovera, Kerendia, REXULTI.

Industry payments across MO — which companies pay providers there.